Hunan Hansen Pharmaceutical Co Ltd (002412) — Cash Flow Reinvestment Rate
Hunan Hansen Pharmaceutical Co Ltd (002412) has a Cash Flow Reinvestment Rate of 0.07x as of September 2025, reinvesting CN¥3.82 Million (capex CN¥3.82 Million ) from operating cash flow of CN¥52.51 Million. See how much free cash does Hunan Hansen Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hunan Hansen Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Hunan Hansen Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see 002412 operating cash flow.
Annual Cash Flow Reinvestment Rate for Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Hunan Hansen Pharmaceutical Co Ltd. See Hunan Hansen Pharmaceutical Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | CN¥93.86 Million | CN¥245.38 Million | CN¥11.10 Million | ▲ +48.6% |
| 2024 | 0.26x | CN¥33.67 Million | CN¥130.78 Million | CN¥11.64 Million | ▼ -37.8% |
| 2023 | 0.41x | CN¥66.58 Million | CN¥160.95 Million | CN¥19.48 Million | ▼ -44.7% |
| 2022 | 0.75x | CN¥107.57 Million | CN¥143.81 Million | CN¥11.50 Million | ▼ -42.8% |
| 2021 | 1.31x | CN¥278.17 Million | CN¥212.54 Million | CN¥229.34 Million | ▲ +52.9% |
| 2020 | 0.86x | CN¥138.85 Million | CN¥162.19 Million | CN¥129.08 Million | ▲ +153.7% |
| 2019 | 0.34x | CN¥55.71 Million | CN¥165.11 Million | CN¥35.71 Million | ▼ -42.5% |
| 2018 | 0.59x | CN¥127.73 Million | CN¥217.52 Million | CN¥64.53 Million | ▼ -44.5% |
| 2017 | 1.06x | CN¥113.40 Million | CN¥107.18 Million | CN¥50.20 Million | ▼ -63.0% |
| 2016 | 2.86x | CN¥460.81 Million | CN¥161.16 Million | CN¥44.91 Million | ▲ +64.0% |
| 2015 | 1.74x | CN¥110.83 Million | CN¥63.57 Million | CN¥75.89 Million | ▲ +101.0% |
| 2014 | 0.87x | CN¥73.75 Million | CN¥85.05 Million | CN¥73.75 Million | ▼ -39.1% |
| 2013 | 1.43x | CN¥108.44 Million | CN¥76.09 Million | CN¥108.44 Million | ▲ +19.2% |
| 2012 | 1.20x | CN¥119.87 Million | CN¥100.23 Million | CN¥119.87 Million | ▲ +69.9% |
| 2011 | 0.70x | CN¥37.90 Million | CN¥53.84 Million | CN¥37.90 Million | ▲ +318.6% |
| 2010 | 0.17x | CN¥3.57 Million | CN¥21.24 Million | CN¥3.57 Million | ▼ -66.4% |
| 2009 | 0.50x | CN¥20.55 Million | CN¥41.02 Million | CN¥20.55 Million | ▲ +30.4% |
| 2008 | 0.38x | CN¥13.04 Million | CN¥33.94 Million | CN¥13.04 Million | ▼ -15.6% |
| 2007 | 0.46x | CN¥17.18 Million | CN¥37.75 Million | CN¥17.18 Million | — |